Education
About Us
Working with TipRanks
Follow Us
Astrazeneca Plc (AZN)
NASDAQ:AZN
Total Valuation
AstraZeneca has a market cap or net worth of $275.87B. The enterprise value is $264.05B.
Market Cap$275.87B
Enterprise Value$264.05B
Share Statistics
AstraZeneca has 3,101,425,800 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,101,425,800
Owned by Insiders―
Owned by Institutions3.27%
Financial Efficiency
AstraZeneca’s return on equity (ROE) is 0.17 and return on invested capital (ROIC) is 10.30%.
Return on Equity (ROE)0.17
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)10.30%
Return on Capital Employed (ROCE)0.13
Revenue Per Employee573.41K
Profits Per Employee92.16K
Employee Count94,300
Asset Turnover0.52
Inventory Turnover1.93
Valuation Ratios
The current PE Ratio of AstraZeneca is 29.4. AstraZeneca’s PEG ratio is -0.71.
PE Ratio29.4
PS Ratio3.76
PB Ratio4.98
Price to Fair Value4.98
Price to FCF27.92
Price to Operating Cash Flow20.55
PEG Ratio-0.71
Income Statement
In the last 12 months, AstraZeneca had revenue of 54.07B and earned 7.04B in profits. Earnings per share was 1.14.
Revenue54.07B
Gross Profit43.87B
Operating Income10.00B
Pretax Income8.69B
Net Income7.04B
EBITDA15.44B
Earnings Per Share (EPS)1.14
Cash Flow
In the last 12 months, operating cash flow was 15.14B and capital expenditures -3.99B, giving a free cash flow of 11.15B billion.
Operating Cash Flow15.14B
Free Cash Flow11.15B
Free Cash Flow per Share3.59
Dividends & Yields
AstraZeneca pays an annual dividend of $0.515, resulting in a dividend yield of 1.76%
Dividend Per Share$0.515
Dividend Yield1.76%
Payout Ratio34.28%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.23
52-Week Price Change43.50%
50-Day Moving Average82.13
200-Day Moving Average74.78
Relative Strength Index (RSI)68.57
Average Volume (3m)5.08M
Important Dates
AstraZeneca upcoming earnings date is Feb 5, 2026, Before Open (Confirmed).
Last Earnings DateNov 6, 2025
Next Earnings DateFeb 5, 2026
Ex-Dividend DateAug 08, 2025
Financial Position
AstraZeneca as a current ratio of 0.93, with Debt / Equity ratio of 73.43%
Current Ratio0.93
Quick Ratio0.74
Debt to Market Cap0.14
Net Debt to EBITDA1.60
Interest Coverage Ratio5.95
Taxes
In the past 12 months, AstraZeneca has paid 1.65B in taxes.
Income Tax1.65B
Effective Tax Rate0.19
Enterprise Valuation
AstraZeneca EV to EBITDA ratio is 14.75, with an EV/FCF ratio of 31.30.
EV to Sales4.21
EV to EBITDA14.75
EV to Free Cash Flow31.30
EV to Operating Cash Flow19.20
Balance Sheet
AstraZeneca has $8.18B in cash and marketable securities with $32.66B in debt, giving a net cash position of -$24.48B billion.
Cash & Marketable Securities$8.18B
Total Debt$32.66B
Net Cash-$24.48B
Net Cash Per Share-$7.89
Tangible Book Value Per Share-$5.59
Margins
Gross margin is 72.60%, with operating margin of 18.50%, and net profit margin of 13.01%.
Gross Margin72.60%
Operating Margin18.50%
Pretax Margin16.07%
Net Profit Margin13.01%
EBITDA Margin28.55%
EBIT Margin19.18%
Analyst Forecast
The average price target for AstraZeneca is $94.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$94.00
Price Target Upside5.50% Upside
Analyst ConsensusStrong Buy
Analyst Count5
Revenue Growth Forecast12.95%
EPS Growth Forecast44.28%